Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany

Werner Solbach, Julia Schiffner, Insa Backhaus, David Burger, Ralf Staiger, Bettina Tiemer, Andreas Bobrowski, Timothy Hutchings, Alexander Mischnik
doi: https://doi.org/10.1101/2020.05.30.20111393
Werner Solbach
1University of Luebeck, Center for Infection and Inflammation Research, Luebeck, Germany
2Health Protection Authority, City of Luebeck, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: werner.solbach@uni-luebeck.de
Julia Schiffner
2Health Protection Authority, City of Luebeck, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Insa Backhaus
2Health Protection Authority, City of Luebeck, Luebeck, Germany
3Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Burger
4Municipal Statistics Department, City of Luebeck, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Staiger
5Gemeinschaftspraxis Huextertor, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bettina Tiemer
6Laboraerztliche Gemeinschaftspraxis Luebeck, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Bobrowski
6Laboraerztliche Gemeinschaftspraxis Luebeck, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Hutchings
4Municipal Statistics Department, City of Luebeck, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Mischnik
2Health Protection Authority, City of Luebeck, Luebeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

This explorative monocentric study shows IgA and IgG antibody profiles from 110 patients with self-reported mild to moderate, or no COVID-19 related symptoms after laboratory-confirmed infection with SARS-CoV-2. The study region is in an urban and well-defined environment in a low-incidence region in Northern Germany. We found that approx. 70 % of the patients developed sustainable antibodies 3 weeks or later after the infection. In about 30 % of the patients with mild to moderate symptoms, no significant antibodies could be detected in two consecutive analyses. Conversely, out of ten patients without symptoms, four were repeatedly positive. Expectedly, six had no specific antibodies. The data indicate that antibody-positivity is a useful indicator of a previous SARS-CoV-2 infection. Negative antibodies do not rule out SARS-CoV-2 infection. Future studies need to determine the functionality of the antibodies in terms of personal protection and ability to transmit the virus.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No financial support.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was carried out in accordance with the Declaration of Helsinki and the guidelines of the International Conference for Harmonization for Good Clinical Practice. The study was approved by the local Ethics Committee at the University of Luebeck.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All relevant data for submission and further analysis are available.

  • Abbreviations

    COVID-19
    coronavirus disease 19
    ELISA
    enzyme-linked immunosorbent assay
    IgG/A
    immunoglobulin G/A
    rtPCR
    real-time polymerase chain reaction
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted June 02, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany
    Werner Solbach, Julia Schiffner, Insa Backhaus, David Burger, Ralf Staiger, Bettina Tiemer, Andreas Bobrowski, Timothy Hutchings, Alexander Mischnik
    medRxiv 2020.05.30.20111393; doi: https://doi.org/10.1101/2020.05.30.20111393
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany
    Werner Solbach, Julia Schiffner, Insa Backhaus, David Burger, Ralf Staiger, Bettina Tiemer, Andreas Bobrowski, Timothy Hutchings, Alexander Mischnik
    medRxiv 2020.05.30.20111393; doi: https://doi.org/10.1101/2020.05.30.20111393

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (143)
    • Anesthesia (47)
    • Cardiovascular Medicine (419)
    • Dentistry and Oral Medicine (72)
    • Dermatology (49)
    • Emergency Medicine (147)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (172)
    • Epidemiology (4904)
    • Forensic Medicine (3)
    • Gastroenterology (185)
    • Genetic and Genomic Medicine (689)
    • Geriatric Medicine (72)
    • Health Economics (193)
    • Health Informatics (636)
    • Health Policy (322)
    • Health Systems and Quality Improvement (209)
    • Hematology (85)
    • HIV/AIDS (157)
    • Infectious Diseases (except HIV/AIDS) (5405)
    • Intensive Care and Critical Care Medicine (333)
    • Medical Education (96)
    • Medical Ethics (24)
    • Nephrology (77)
    • Neurology (692)
    • Nursing (42)
    • Nutrition (115)
    • Obstetrics and Gynecology (128)
    • Occupational and Environmental Health (211)
    • Oncology (447)
    • Ophthalmology (140)
    • Orthopedics (36)
    • Otolaryngology (91)
    • Pain Medicine (37)
    • Palliative Medicine (18)
    • Pathology (131)
    • Pediatrics (201)
    • Pharmacology and Therapeutics (131)
    • Primary Care Research (88)
    • Psychiatry and Clinical Psychology (787)
    • Public and Global Health (1831)
    • Radiology and Imaging (328)
    • Rehabilitation Medicine and Physical Therapy (142)
    • Respiratory Medicine (257)
    • Rheumatology (87)
    • Sexual and Reproductive Health (69)
    • Sports Medicine (63)
    • Surgery (102)
    • Toxicology (23)
    • Transplantation (29)
    • Urology (37)